(Q43848295)

English

Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE-binding capacity: candidates for grass pollen-specific immunotherapy

scientific article published in January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE-binding capacity: candidates for grass pollen-specific immunotherapy (English)

1 reference

Europe PubMed Central

27 November 2017

0 references

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

27 November 2017

13

object named as

Rudolf Valenta

1 reference

Europe PubMed Central

27 November 2017

author name string

Ines Swoboda

1

1 reference

Europe PubMed Central

27 November 2017

Nicole De Weerd

2

1 reference

Europe PubMed Central

27 November 2017

Prem L Bhalla

3

1 reference

Europe PubMed Central

27 November 2017

Verena Niederberger

4

1 reference

Europe PubMed Central

27 November 2017

W R Sperr

5

1 reference

Europe PubMed Central

27 November 2017

Peter Valent

6

1 reference

Europe PubMed Central

27 November 2017

Helga Kahlert

7

1 reference

Europe PubMed Central

27 November 2017

Helmut Fiebig

8

1 reference

Europe PubMed Central

27 November 2017

Petra Verdino

9

1 reference

Europe PubMed Central

27 November 2017

Christof Ebner

11

1 reference

Europe PubMed Central

27 November 2017

Susanne Spitzauer

12

1 reference

Europe PubMed Central

27 November 2017

Mohan B Singh

14

1 reference

Europe PubMed Central

27 November 2017

language of work or name

0 references

publication date

1 January 2002

1 reference

Europe PubMed Central

27 November 2017

European Journal of Immunology

1 reference

Europe PubMed Central

27 November 2017

32

1 reference

Europe PubMed Central

27 November 2017

1

1 reference

Europe PubMed Central

27 November 2017

270-280

1 reference

Europe PubMed Central

27 November 2017

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Reduction in IgE binding to allergen variants generated by site-directed mutagenesis: contribution of disulfide bonds to the antigenic structure of the major house dust mite allergen Der p 2.

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy.

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Engineering of hypoallergenic mutants of the Brassica pollen allergen, Bra r 1, for immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Isolation of cDNA encoding a newly identified major allergenic protein of rye-grass pollen: intracellular targeting to the amyloplast

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Cloning of a cDNA encoding a group-V (group-IX) allergen isoform from rye-grass pollen that demonstrates specific antigenic immunoreactivity

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Mapping of the antigenic and allergenic epitopes of Lol p VB using gene fragmentation.

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Molecular basis of IgE-recognition of Lol p 5, a major allergen of rye-grass pollen.

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Identification of T-cell epitopes of Lol p 9, a major allergen of ryegrass (Lolium perenne) pollen

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

PHD: predicting one-dimensional protein structure by profile-based neural networks

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Prediction of protein secondary structure at better than 70% accuracy

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

The receptor with high affinity for immunoglobulin E.

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

T cell receptor gene diversity and selection

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Interleukin 3 activates human blood basophils via high-affinity binding sites.

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Immunologic changes associated with allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Recombinant allergen fragments as candidate preparations for allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Immunologic characterization of purified recombinant timothy grass pollen (Phleum pratense) allergens (Phl p 1, Phl p2, Phl p 5)

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Calculation of protein conformation from circular dichroism

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Application of allergen research to diagnosis and immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Reactivity of T cells with grass pollen allergen extract and allergoid

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200201%2932%3A1%3C270%3A%3AAID-IMMU270%3E3.0.CO%3B2-X

21 January 2018

Identifiers

10.1002/1521-4141(200201)32:1<270::AID-IMMU270>3.0.CO;2-X

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43848295&oldid=2103855877"